| pubmed-article:20830537 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0040132 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C1514983 | lld:lifeskim |
| pubmed-article:20830537 | lifeskim:mentions | umls-concept:C0872172 | lld:lifeskim |
| pubmed-article:20830537 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:20830537 | pubmed:dateCreated | 2010-12-14 | lld:pubmed |
| pubmed-article:20830537 | pubmed:abstractText | Focal thyroid incidentaloma by F-18 2-deoxy-2-F18-fluoro-D: -glucose (FDG) positron emission tomography (PET) has been reported 1-4% of cancer patients and normal healthy population, with a risk of cancer ranging 14-50%. The aim of this study was to investigate the prevalence of thyroid incidentaloma in F-18 FDG PET/CT and risk of cancer, usefulness of visual and SUV(max) and SUV(mean) differentiating malignant nodules and to define the predictable variables. | lld:pubmed |
| pubmed-article:20830537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20830537 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20830537 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20830537 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20830537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20830537 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20830537 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20830537 | pubmed:issn | 1864-6433 | lld:pubmed |
| pubmed-article:20830537 | pubmed:author | pubmed-author:KimIn JooIJ | lld:pubmed |
| pubmed-article:20830537 | pubmed:author | pubmed-author:KimSeong-Jang... | lld:pubmed |
| pubmed-article:20830537 | pubmed:author | pubmed-author:KimYong-KiYK | lld:pubmed |
| pubmed-article:20830537 | pubmed:author | pubmed-author:KimBo HyunBH | lld:pubmed |
| pubmed-article:20830537 | pubmed:author | pubmed-author:NaMin AMA | lld:pubmed |
| pubmed-article:20830537 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20830537 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:20830537 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20830537 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20830537 | pubmed:pagination | 721-8 | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:meshHeading | pubmed-meshheading:20830537... | lld:pubmed |
| pubmed-article:20830537 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20830537 | pubmed:articleTitle | Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. | lld:pubmed |
| pubmed-article:20830537 | pubmed:affiliation | Department of Internal Medicine, Pusan National University Hospital, Busan, 602-739, Republic of Korea. | lld:pubmed |
| pubmed-article:20830537 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20830537 | lld:pubmed |
